The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Arovi 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe

Laboratorios Farmacéuticos ROVI, S.A.PA1995/001/003

Main Information

Trade NameArovi 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe
Active SubstancesEnoxaparin sodium
Dosage FormSolution for injection in pre-filled syringe
Licence HolderLaboratorios Farmacéuticos ROVI, S.A.
Licence NumberPA1995/001/003

Group Information

ATC CodeB01AB Heparin group
B01AB05 enoxaparin


License statusAuthorised
Licence Issued27/07/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back